Alcon Research
Clinical trials sponsored by Alcon Research, explained in plain language.
-
New lens study checks if patients can ditch their glasses
Disease control CompletedThis study followed 155 people who had already received Clareon Vivity or Clareon Monofocal lens implants in both eyes during cataract surgery. Researchers measured how well participants could see at different distances and asked about their need for glasses. The goal was to coll…
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New vs. standard lens: which gives better vision after cataract surgery?
Disease control CompletedThis study compared two types of artificial lenses implanted during cataract surgery. 87 participants had one type of lens in one eye and the other type in their other eye. Researchers measured how well each lens improved distance vision and overall safety over 6 months.
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New eye drops take aim at Glaucoma's silent threat
Disease control CompletedThis study tested two new eye drop formulas to see if they safely lower high eye pressure, a major risk factor for glaucoma. Over 400 adults with open-angle glaucoma or ocular hypertension used the drops for 7 or 28 days. Researchers compared the new drops to existing treatments …
Phase: PHASE2 • Sponsor: Alcon Research • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New lens design aims to sharpen vision after cataract removal
Disease control CompletedThis study tested a newer version of an artificial lens against the standard version to see which is safer and more effective for vision after cataract surgery. It involved 71 people who had cataract surgery in both eyes, with each eye receiving a different lens for comparison. R…
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Five-Year checkup: are these Vision-Correcting lenses still safe?
Disease control CompletedThis study followed people in Spain who had PanOptix lens implants for 3 to 5 years to check long-term safety and performance. Researchers collected data from 211 participants who already had the lenses implanted to see how well they worked years later and if any problems develop…
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Contact lens showdown: which lens works best for aging eyes?
Symptom relief CompletedThis study tested two different brands of multifocal contact lenses to see which one provides better vision for people with presbyopia (age-related blurry near vision). 106 experienced contact lens wearers tried each type of lens for about two weeks. Researchers measured how well…
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Apr 04, 2026 00:35 UTC
-
New eye drops aim to clear up red eyes fast
Symptom relief CompletedThis study tested whether a prescription eye drop was safe and effective at reducing redness from minor eye irritation. It compared the active eye drop to a placebo (vehicle) drop in 159 adults in the United States. Researchers measured how well and how quickly the drops worked t…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New eye drop formula tested to quickly soothe red, irritated eyes
Symptom relief CompletedThis study tested whether a new eye drop formula called FID 123320 could safely reduce eye redness caused by minor irritations. Researchers compared the drops to a placebo in 283 participants, including both adults and children ages 5-17. The main goal was to see how well and how…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
New contact lenses put to the test for clearer vision
Symptom relief CompletedThis study tested two different types of monthly replacement contact lenses designed to help people with both astigmatism and age-related vision changes (presbyopia). 95 regular contact lens wearers tried each lens type for about 30 days to see how well they worked for distance v…
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
New eye drop shows promise for boosting natural tears
Symptom relief CompletedThis study tested whether a new eye drop called AR-15512 could quickly increase tear production in people with dry eye disease. Researchers measured tear levels in 81 participants' eyes before and after using the drops during a single clinic visit. The goal was to see if this tre…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
New eye drop safety tested against common tear
Symptom relief CompletedThis study aimed to check the safety of a new eye drop for dry eye disease by comparing it to a standard artificial tear. It involved 55 participants with dry eyes who tried different sequences of the new drop and the standard one. The main goal was to see what percentage of peop…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
New eye drop tested for dry eye relief
Symptom relief CompletedThis study tested a new eye lubricant to see if it is safe and effective for reducing the symptoms of dry eye disease. About 188 adults with mild to moderate dry eye used the drops for 30 days. Researchers measured how much the drops reduced the bother caused by dry eye symptoms.
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Mar 11, 2026 14:54 UTC
-
Scientists test which contact lens fits best
Knowledge-focused CompletedThis study aimed to see how well different sizes and shapes of a specific soft contact lens fit people with nearsightedness. Researchers tested the lenses on 257 regular contact lens wearers to find the best fit. They measured how the lenses moved and centered on the eye right af…
Phase: NA • Sponsor: Alcon Research • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC